Skip to content

Author

P. Cameli

We have 3 of 252 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Biomarkers in ANCA-Associated Vasculitis-Associated Interstitial Lung Disease: A Scoping Review

Background: Interstitial lung disease (ILD) is an increasingly recognized manifestation of ANCA-associated vasculitis (AAV) and is associated with substantial morbidity and mortality. The marked biological and clinical heterogeneity of AAV-associated ILD (AAV-ILD) poses major challenges for diagnosis, prognostic strati...

Tommaso Pianigiani, A. Dilroba, Michael McConville et al. · 0 citations
Review Open access Aug 2026

MicroRNAs in IPF and Lung Cancer: Convergent and Divergent Mechanisms: a systematic review.

A framework for understanding miRNA dysregulation in IPF and LC is provided, with direct implications for biomarker validation and therapeutic targeting, by systematically integrating mechanistic and regulatory evidence.

S. Gangi, Sofia Marrucci, Chiara Diana et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.